Previous 10 | Next 10 |
Image source: The Motley Fool. Smith & Nephew plc (NYSE: SNN) Q4 2020 Earnings Call Feb 18, 2021 , 3:30 a.m. ET Operator Continue reading For further details see: Smith & Nephew plc (SNN) Q4 2020 Earnings Call Transcript
The following slide deck was published by Smith & Nephew plc in conjunction with their 2020 Q4 earnings call. For further details see: Smith & Nephew plc 2020 Q4 - Results - Earnings Call Presentation
Smith & Nephew plc (SNN) Q4 2020 Results Earnings Conference Call February 18, 2021, 03:30 AM ET Company Participants Roland Diggelmann - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Lisa Clive - Bernstein Michael Jungling - Morgan S...
Smith & Nephew (SNN) declares $0.231/share final dividend (about $0.462/ADS).Payable May 12; for shareholders of record April 6; ex-div April 5.See SNN Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Smith & Nephew declares $0.231 dividend ...
Smith & Nephew (SNN) down 5% premarket after FY results missed analyst expectations.Revenues: $4,560M (-11.2%). The revenue was down 12.1% on underlying basis.Orthopaedics: $1,917M (-13.7%); Sports Medicine & ENT: $1,333M (-13.2%); Advanced Wound Management: $1,310M (-5.1%)....
Zimmer Biomet came in a little light for the fourth quarter, as the pandemic led to an unexpected slowdown in elective procedures late in the quarter. Sustained share gains from Stryker will remain challenging, but the expansion of Rosa placements and the new Persona IQ will help grow...
Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications PR Newswire LONDON , Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology busines...
The pandemic is delaying elective procedures, which led the company to issue a profit warning this week. I expect that to continue across 2021 and perhaps into 2022. While I continue to see long-term potential, I see limited upside from today's price in the first half. The int...
Smith+Nephew partners with Movemedical to streamline inventory management and improve customer experience PR Newswire LONDON , Jan. 12, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the successful in...
New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹ LONDON , Dec. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinica...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...